AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2012
Sep 14, 2012
35124_dirs_2012-09-14_2674f7e6-2510-4e10-ab82-a85c39ce0488.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-14
Reporting Person: Tardugno Michael H (CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-14 | Celsion Corporation Common Stock | P | 3100 | $5.03 | Acquired | 194114 | Direct |
| 2012-09-14 | Celsion Corporation Common Stock | P | 1900 | $5.04 | Acquired | 196014 | Direct |
Footnotes
F1: The shares of common stock were purchased by the officer on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23